IP Library Granted Patent US 9,919,018
Granted Patent B2
US 9,919,018 · App. 15/351,097 · Granted Mar 20, 2018

Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract

Inventors: Joanna E. Ellington (Valleyford, WA); G. Dennis Clifton (Valleyford, WA)
Assignee: Fairhaven Health, LLC
A61K36/537A61K8/042A61K8/60A61K8/97A61K9/0014A61K9/0034A61K9/06A61K31/7004A61K47/02A61K47/06A61K47/10A61K47/12A61K47/22A61K47/26A61K47/32A61K47/38A61Q19/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,919,018
App. No.
15/351,097
Granted
Mar 20, 2018
Kind
B2
Abstract

The present disclosure provides compositions and methods for making and using topical compositions comprised of an isotonic, biome-friendly solution containing xylose and/or a Salvia extract. The compositions are useful for, for example, maintaining or enhancing female lower reproductive tract (LRT) homeostasis and physiological function. In particular, topical compositions of this disclosure can be formulated for use as a freshening, menopausal, fertility, and/or perineal composition.

Claims (76)

1. A topical, isotonic freshening vaginal gel composition, comprising:

xylose at a total concentration ranging from about 0.01% to about 1% by weight;

a Salvia extract at a total concentration ranging from about 0.01% to about 1% by weight;

a non-irritating viscosity increasing agent at a total concentration ranging from about 0.1% to about 25% by weight;

a surfactant at a total concentration ranging from about 0.25% to about 10% by weight;

a buffering agent at a total concentration ranging from about 0.05% to about 2.5% by weight;

a pH modifying agent at a total concentration ranging from about 0.001% to about 2% by weight;

an osmolality adjuster at a total concentration ranging from about 0.1% to about 1% by weight; and

water at a total concentration ranging from about 60% to about 99% by weight;

wherein the composition has a pH ranging from about 3.5 to about 6.8.

2. The composition of claim 1 , wherein the non-irritating viscosity-increasing agent is a cellulose ether, a carbomer, a polyoxazoline, or any combination thereof.

3. The composition of claim 2 , wherein the non-irritating viscosity-increasing agent is: (a) a carbomer, wherein the carbomer is carbomer homopolymer type B at a total concentration ranging from about 0.1% to about 3% by weight; or (b) a polyoxazoline, wherein the polyoxazoline is poly(2-methyl-2-oxazoline) at a total concentration ranging from about 5% to about 10% by weight.

4. The composition of claim 1 , wherein the surfactant is a cetyl hydroxyethylcellulose, polyvinyl alcohol, or both.

5. The composition of claim 1 , wherein the surfactant is: (a) a cetyl hydroxyethylcellulose at a total concentration ranging from about 0.25% to about 5% by weight; or (b) a polyvinyl alcohol at a total concentration ranging from about 1% to about 3% by weight.

6. The composition of claim 1 , further comprising a paraben-free preservative at a total concentration ranging from about 0.005% to 5% by weight.

7. The composition of claim 6 , wherein the paraben-free preservative is a phenethyl alcohol, caprylyl glycol, oleuropein, acemannan, carvacrol, an ascorbate, cranberry extract, or any combination thereof.

8. The composition of claim 1 , further comprising a paraben-free preservative, wherein the paraben-free preservative is: (a) a phenethyl alcohol and caprylyl glycol together at a total concentration ranging from about 0.02% to about 1.5% by weight; (b) a phenethyl alcohol, caprylyl glycol and a sodium ascorbate, together at a total concentration ranging from about 0.5% to about 2% by weight; or (c) a cranberry extract at a total concentration ranging from about 0.01% to about 2.5% by weight.

9. The composition of claim 1 , wherein the buffering agent is lactic acid, sodium lactate, ascorbic acid, sodium ascorbate, sodium phosphate, acetic acid, sodium acetate, citric acid, or any combination thereof.

10. The composition of claim 1 , wherein the buffering agent is (a) lactic acid and sodium lactate together at a total concentration ranging from about 0.4% to about 1% by weight or (b) ascorbic acid and sodium ascorbate at a total concentration ranging from about 0.5% to about 2% by weight.

11. The composition of claim 1 , wherein the osmolality adjuster is sodium chloride, potassium chloride, or both.

12. The composition of claim 1 , wherein the pH modifying agent is ammonia, ammonium carbonate, diethanolamine, monoethanolamine, potassium hydroxide, potassium phosphate dibasic, sodium bicarbonate, sodium borate, sodium carbonate, sodium hydroxide, sodium lactate, sodium phosphate dibasic, trolamine, or any combination thereof.

13. The composition of claim 1 , wherein the pH modifying agent is sodium hydroxide at a total concentration ranging from about 0.001% to about 1% by weight.

14. The composition of claim 1 , wherein the Salvia extract is obtained from Salvia sclarea, Salvia hispanica, Salvia plebeia , or combinations thereof.

15. The composition of claim 1 , wherein:

the Salvia extract comprises a Salvia sclarea extract, wherein the Salvia sclarea extract is at a concentration ranging from about 0.025% to about 0.075% by weight;

the non-irritating viscosity-increasing agent comprises poly(2-methyl-2-oxazoline) at a concentration ranging from about 1% to about 10% by weight;

the surfactant comprises polyvinyl alcohol and cetyl hydroxyethylcellulose together at a total concentration ranging from about 1% to about 9% by weight;

the buffering agent comprises lactic acid and sodium lactate together at a total concentration ranging from about 0.5% to about 1% by weight;

the osmolality adjuster comprises sodium chloride at a concentration ranging from about 0.1% to about 0.7% by weight;

the pH modifying agent comprises sodium hydroxide at a concentration ranging from about 0.001% to about 1% by weight; and

the water is at a concentration ranging from about 75% to about 98% by weight.

16. The composition of claim 1 , wherein:

the Salvia extract comprises a Salvia sclarea extract, wherein the Salvia sclarea extract is at a concentration ranging from about 0.025% to about 0.075% by weight;

the non-irritating viscosity-increasing agent comprises poly(2-methyl-2-oxazoline) at a concentration ranging from about 5% to about 10% by weight;

the buffering agent comprises lactic acid and sodium lactate together at a total concentration ranging from about 0.5% to about 1% by weight;

the osmolality adjuster comprises sodium chloride at a total concentration ranging from about 0.1% to about 0.7% by weight;

the water is at a concentration ranging from about 85% to about 98% by weight;

the pH modifying agent comprises sodium hydroxide at a concentration ranging from about 0.001% to about 1% by weight; and

the composition further comprises a paraben-free preservative comprising, phenethyl alcohol and caprylyl glycol together at a total concentration ranging from about 0.2% to about 0.7% by weight.

17. The composition of claim 1 , wherein:

the Salvia extract comprises a Salvia sclarea extract, wherein the Salvia sclarea extract is at a concentration ranging from about 0.025% to about 0.075% by weight;

the non-irritating viscosity-increasing agent comprises carbomer homopolymer type B at a total concentration ranging from about 0.1% to about 3% by weight;

the surfactant comprises cetyl hydroxyethylcellulose at a total concentration ranging from about 0.5% to about 1.5% by weight;

the buffering agent comprises lactic acid and sodium lactate together at a total concentration ranging from about 0.4% to about 1% by weight;

the osmolality adjuster comprises sodium chloride at a total concentration ranging from about 0.1% to about 0.7% by weight;

the water is at a concentration ranging from about 90% to about 98% by weight;

the pH modifying agent comprises sodium hydroxide at a concentration ranging from about 0.001% to about 1% by weight; and

the composition further comprises a paraben-free preservative comprising phenethyl alcohol and caprylyl glycol together at a total concentration ranging from about 0.2% to about 0.7% by weight.

18. The composition of claim 1 , wherein:

the Salvia extract comprises a Salvia sclarea extract, wherein the Salvia sclarea extract is at a concentration ranging from about 0.025% to about 0.075% by weight;

the non-irritating viscosity-increasing agent comprises carbomer homopolymer type B at a total concentration ranging from about 0.1% to about 3% by weight;

the surfactant comprises cetyl hydroxyethylcellulose at a total concentration ranging from about 0.5% to about 1.5% by weight;

the buffering agent comprises ascorbic acid and sodium ascorbate together at a total concentration ranging from about 0.5% to about 1.2% by weight;

the osmolality adjuster comprises sodium chloride at a total concentration ranging from about 0.1% to about 0.7% by weight;

the water is at a concentration ranging from about 90% to about 98% by weight; and

the composition further comprises a paraben-free preservative comprising phenethyl alcohol and caprylyl glycol together at a total concentration ranging from about 0.2% to about 0.7% by weight.

19. The composition of claim 1 , wherein:

the Salvia extract comprises Salvia sclarea extract, wherein the Salvia sclarea extract is at a concentration ranging from about 0.025% to about 0.075% by weight;

the non-irritating viscosity-increasing agent comprises carbomer homopolymer type B at a total concentration ranging from about 1% to about 3% by weight;

the surfactant comprises polyvinyl alcohol at a total concentration ranging from about 1% to about 3% by weight;

the buffering agent comprises lactic acid and sodium lactate together at a total concentration ranging from about 0.5% to about 1% by weight;

the osmolality adjuster comprises sodium chloride at a total concentration ranging from about 0.1% to about 0.7% by weight;

the water is at a concentration ranging from about 90% to about 98% by weight; and

the pH modifying agent comprises sodium hydroxide at a concentration ranging from about 0.001% to about 1% by weight.

20. The composition of claim 17 , wherein the paraben-free preservative comprises a solution of phenethyl alcohol and caprylyl glycol together at a total concentration ranging from about 0.2% to about 0.7% by weight, wherein the solution comprises phenethyl alcohol in an amount of 56%-60% and caprylyl glycol in an amount of 40%-44%.

21. The composition of claim 18 , wherein the paraben-free preservative comprises a solution of phenethyl alcohol and caprylyl glycol together at a total concentration ranging from about 0.2% to about 0.7% by weight, wherein the solution comprises phenethyl alcohol in an amount of 56%-60% and caprylyl glycol in an amount of 40%-44%.

22. The composition of claim 17 , wherein the composition has a pH of about 3.5 to about 5.5.

23. The composition of claim 18 , wherein the composition has a pH of about 3.5 to about 5.5.

24. A method for enhancing vaginal ecosystem homeostasis of the lower reproductive tract, comprising topically applying an effective amount of the composition of claim 1 to the lower reproductive tract of a human female subject.

25. The method of claim 24 , wherein the vaginal microbiota of the human female subject is not reduced greater than 25% following topical application of the composition to the lower reproductive tract as compared to an untreated control human female subject or prior to topical application of the composition to the lower reproductive tract.

26. A method for increasing hydration of the vaginal mucosa, comprising topically applying an effective amount of the composition of claim 1 to the lower reproductive tract of a human female subject.

27. The method of claim 26 , wherein the vaginal microbiota of the human female subject is not reduced greater than 25% following topical application of the composition to the lower reproductive tract as compared to an untreated control human female subject or prior to topical application of the composition to the lower reproductive tract.

28. A method of cleansing the lower reproductive tract or controlling unwanted odor of the lower reproductive tract comprising topically applying an effective amount of the composition of claim 1 to the lower reproductive tract of a human female subject.

29. The method of claim 28 , wherein the vaginal microbiota of the human female subject is not reduced greater than 25% following topical application of the composition to the lower reproductive tract as compared to an untreated control human female subject or prior to topical application of the composition to the lower reproductive tract.

30. A method of maintaining physiological pH of the vagina comprising topically applying an effective amount of the composition of claim 1 to the lower reproductive tract of a human female subject.

31. The method of claim 30 , wherein the vaginal microbiota of the human female subject is not reduced greater than 25% following topical application of the composition to the lower reproductive tract as compared to an untreated control human female subject or prior to topical application of the composition to the lower reproductive tract.

Assignments (4)
SECURITY INTEREST Recorded Apr 22, 2022
From: FAIRHAVEN HEALTH, L.L.C.
To: BALANCE POINT CAPITAL PARTNERS V, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 059678/0111 →
SECURITY INTEREST Recorded Apr 21, 2022
From: FAIRHAVEN HEALTH, L.L.C.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 059671/0774 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2016
From: ELLINGTON, JOANNA E.; CLIFTON, G. DENNIS
To: BIOORIGYN, LLC
Reel/Frame 040348/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2016
From: BIOORIGYN, LLC
To: FAIRHAVEN HEALTH, LLC
Reel/Frame 040348/0143 →
Continuity (3)
Continuation 15207307 · Jul 11, 2016
Provisional Application 62323516 · Apr 15, 2016
Related Publication 20170296610A1 · Oct 19, 2017